Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study
JNCI Cancer Spectrum · 2024
DOI: 10.1093/jncics/pkae070 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Margarita Cariolou und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Body Mass Index, Adiposity, Waist Circumference. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Cancer Research UK, World Cancer Research Fund network of charities.
Abstract (Originalsprache)
Background
Adiposity has been characterized as a modifiable risk factor for prostate cancer. Its association with outcomes after prostate cancer diagnosis, however, must be better understood, and more evidence is needed to facilitate the development of lifestyle guidance for patients with prostate cancer.
Methods
We investigated the associations between adiposity indices close to prostate cancer diagnosis (up to 2 years before or up to 5 years after diagnosis) and mortality in 1968 men of the European Prospective Investigation into Cancer and Nutrition cohort. Men were followed up for a median of 9.5 years. Cox proportional hazards models were adjusted for age and year of diagnosis, disease stage and grade, and smoking history and stratified by country.
Results
Each 5-unit increment in prediagnosis or postdiagnosis body mass index combined was associated with a 30% higher rate of all-cause mortality and a 49% higher rate of prostate cancer–specific mortality. Similarly, each 5-unit increment in prediagnosis body mass index was associated with a 35% higher rate of all-cause mortality and a 51% higher rate of prostate cancer–specific mortality. The associations were less strong for postdiagnosis body mass index, with a lower number of men in analyses. Less clear positive associations were shown for waist circumference, hip circumference, and waist to hip ratio, but data were limited.
Conclusions
Elevated levels of adiposity close to prostate cancer diagnosis could lead to higher risk of mortality; therefore, men are encouraged to maintain a healthy weight. Additional research is needed to confirm whether excessive adiposity after prostate cancer diagnosis could worsen prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
- Unit of Nutrition and Cancer, Cancer Epidemiology and Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
- Danish Cancer Institute, Diet, Cancer and Health, Copenhagen, Denmark.
- Department of Public Health, University of Copenhagen, Copenhagen , Denmark.
- International Agency for Research on Cancer, Lyon, France.
ORCID-Profile: Margarita Cariolou, Sofia Christakoudi, Tim Key, Raul Zamora-Ros, Kristina Elin T Petersen, Anne Tjønneland, Rudolf Kaaks, Giovanna Masala, Claudia Agnoli, Rosario Tumino, Amaia Aizpurua, Miguel Rodriguez-Barranco, Marcela Guevara, Dagfinn Aune, Doris S M Chan, Konstantinos K Tsilidis
Förderung
- Medical Research Council
- Cancer Research UK
- World Cancer Research Fund network of charities
- World Cancer Research Fund
- World Health Organization
- American Institute for Cancer Research
Zitieren
APA
Cariolou, M., Christakoudi, S., Gunter, M. J., Key, T., Pérez-Cornago, A., Travis, R., Zamora-Ros, R., Petersen, K. E. T., Tjønneland, A., Weiderpass, E., Kaaks, R., Seibold, P., Inan-Eroglu, E., Schulze, M. B., Masala, G., Agnoli, C., Tumino, R., Di Girolamo, C., Aizpurua, A., …, & Tsilidis, K. K. (2024). Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae070
Vancouver
Cariolou M, Christakoudi S, Gunter MJ, Key T, Pérez-Cornago A, Travis R, et al. Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae070
BibTeX
@article{Cariolou2024,
author = {Cariolou, Margarita and Christakoudi, Sofia and Gunter, Marc J and Key, Tim and Pérez-Cornago, Aurora and Travis, Ruth and Zamora-Ros, Raul and Petersen, Kristina Elin T and Tjønneland, Anne and Weiderpass, Elisabete and Kaaks, Rudolf and Seibold, Petra and Inan-Eroglu, Elif and Schulze, Matthias B and Masala, Giovanna and Agnoli, Claudia and Tumino, Rosario and Di Girolamo, Chiara and Aizpurua, Amaia and Rodriguez-Barranco, Miguel and Santiuste, Carmen and Guevara, Marcela and Aune, Dagfinn and Chan, Doris S M and Muller, David C and Tsilidis, Konstantinos K},
title = {Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study},
journal = {JNCI Cancer Spectrum},
year = {2024},
doi = {10.1093/jncics/pkae070}
}
EUVIMED